Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Accentis S.A. | D1Z | 21. nov 2024 | 0.02 | 0.00 |
Accentro Real Estate AG | A4Y | 21. nov 2024 | 0.22 | -19.57 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | 21. nov 2024 | 345.85 | +3.39 |
Accesso Technology Group Plc | LQG | 21. nov 2024 | 6.25 | -3.85 |
Acciona SA | AJ3 | 21. nov 2024 | 114.90 | +0.44 |
Acco Brands Corporation | A3B | 21. nov 2024 | 5.35 | 0.00 |
Accolade, Inc. | 4NE1 | 21. nov 2024 | 3.34 | +2.45 |
Acconeer | 2LU | 21. nov 2024 | 0.42 | +0.24 |
Accor | ACR1 | 21. nov 2024 | 8.40 | -1.75 |
Accor SA | ACR | 21. nov 2024 | 42.81 | -0.90 |
Accsys Technologies | 1D8 | 21. nov 2024 | 0.50 | -4.55 |
Accuray Incorporated | XEJ | 21. nov 2024 | 1.71 | 0.00 |
Ace Hardware Indonesia TBK | 4AH1 | 21. nov 2024 | 0.04 | -1.22 |
ACE LIBERTY+STONE LS -,25 | 8MW | 21. nov 2024 | 0.54 | 0.00 |
ACEA SpA | DCA | 21. nov 2024 | 17.34 | +1.88 |
AcelRx Pharmaceuticals | R5XA | 21. nov 2024 | 0.66 | +5.48 |
Acer Incorporated | AC5G | 21. nov 2024 | 4.60 | 0.00 |
ACERINOX ADR 1/2/EO-,25 | ACE | 21. nov 2024 | 4.28 | +0.47 |
Acerinox SA | ACE1 | 21. nov 2024 | 9.16 | +2.46 |
Achieve Life Sciences, Inc. - | SP4P | 21. nov 2024 | 4.00 | -0.12 |
Achilles Therapeutics plc - American Depositary Shares | 698 | 21. nov 2024 | 0.96 | +1.05 |
ACI Worldwide, Inc. | TSA | 21. nov 2024 | 52.50 | +1.94 |
ACINQUE S.P.A. EO 1 | YA2 | 21. nov 2024 | 1.94 | +0.78 |
Ackermans & van Haaren NV | B3K | 21. nov 2024 | 186.00 | +0.22 |
Aclara Resources Inc | JD1 | 21. nov 2024 | 0.26 | +7.44 |
Aclaris Therapeutics, Inc. | 8AT | 21. nov 2024 | 3.77 | -16.53 |
ACM Research, Inc. - Class A | 813 | 21. nov 2024 | 18.23 | +6.27 |
Acma Ltd | AAX1 | 21. nov 2024 | 0.01 | -42.86 |
Acme United Corporation. | UT1 | 21. nov 2024 | 38.80 | -0.51 |
Acom Co Ltd | AK5 | 21. nov 2024 | 2.30 | -2.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.